Seroconversion of JCV antibodies is strongly associated to natalizumab therapy.
Fragoso, Yara Dadalti
Seroconversion of JCV antibodies is strongly associated to natalizumab therapy. [electronic resource] - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Mar 2019 - 112-113 p. digital
Publication Type: Journal Article
1532-2653
10.1016/j.jocn.2018.10.128 doi
Adult
Antibodies, Viral--immunology
Brazil
Female
Humans
Immunologic Factors--adverse effects
JC Virus--immunology
Male
Multiple Sclerosis--drug therapy
Natalizumab--adverse effects
Seroconversion--drug effects
Seroconversion of JCV antibodies is strongly associated to natalizumab therapy. [electronic resource] - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Mar 2019 - 112-113 p. digital
Publication Type: Journal Article
1532-2653
10.1016/j.jocn.2018.10.128 doi
Adult
Antibodies, Viral--immunology
Brazil
Female
Humans
Immunologic Factors--adverse effects
JC Virus--immunology
Male
Multiple Sclerosis--drug therapy
Natalizumab--adverse effects
Seroconversion--drug effects